HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad-Reza Zarrindast Selected Research

Dopamine Antagonists

1/2019The Involvement of D1 and D2 Dopamine Receptors in the Restoration Effect of Left Frontal Anodal, but not Cathodal, tDCS on Streptozocin-Induced Amnesia.
10/2016Function of opioidergic and dopaminergic antagonists on both spatial and object novelty detection deficits induced in rodent model of hepatic encephalopathy.
8/2013Differential mechanisms of opioidergic and dopaminergic systems of the ventral hippocampus (CA₃) in anxiolytic-like behaviors induced by cholestasis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad-Reza Zarrindast Research Topics

Disease

56Amnesia (Dissociative Amnesia)
06/2021 - 08/2004
17Pain (Aches)
05/2023 - 01/2006
17Sleep Deprivation
01/2023 - 01/2016
16Memory Disorders (Memory Loss)
12/2021 - 03/2014
7Substance-Related Disorders (Drug Abuse)
06/2023 - 01/2014
7Cholestasis
06/2023 - 06/2013
6Opioid-Related Disorders (Opiate Addiction)
07/2015 - 07/2009
5Morphine Dependence
07/2023 - 09/2002
5Alzheimer Disease (Alzheimer's Disease)
12/2022 - 04/2014
5Cognitive Dysfunction
04/2022 - 11/2013
4Inflammation (Inflammations)
02/2024 - 12/2020
4Hyperalgesia
05/2023 - 05/2003
4Mental Disorders (Mental Disorder)
01/2022 - 01/2019
3Nervous System Diseases (Neurological Disorders)
01/2023 - 01/2019
3Mood Disorders (Mood Disorder)
01/2022 - 09/2015
3Parkinson Disease (Parkinson's Disease)
12/2021 - 01/2012
3Hypothermia
06/2013 - 09/2002
2Body Weight (Weight, Body)
02/2024 - 01/2019
2Neuroinflammatory Diseases
02/2023 - 01/2022
2Stroke (Strokes)
04/2022 - 01/2020
2Multiple Sclerosis
04/2022 - 02/2020
2Anxiety Disorders (Anxiety Disorder)
01/2022 - 01/2009
2Neuralgia (Stump Neuralgia)
01/2021 - 12/2018
2Hepatic Encephalopathy
12/2020 - 10/2016
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2020 - 01/2020
2Neoplasms (Cancer)
07/2020 - 08/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2020 - 10/2018

Drug/Important Bio-Agent (IBA)

41Morphine (MS Contin)FDA LinkGeneric
07/2023 - 05/2002
14Opioid Analgesics (Opioids)IBA
11/2022 - 05/2002
13Naloxone (Narcan)FDA LinkGeneric
11/2022 - 05/2002
13Sulpiride (neogama)IBA
12/2021 - 08/2004
11SCH 23390IBA
09/2019 - 08/2004
9CannabinoidsIBA
01/2023 - 01/2015
8NicotineFDA Link
01/2019 - 05/2002
7Dopamine (Intropin)FDA LinkGeneric
01/2023 - 09/2002
7CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2023 - 03/2013
7Anti-Anxiety Agents (Anxiolytics)IBA
11/2022 - 08/2013
7MuscimolIBA
01/2020 - 01/2006
6AntioxidantsIBA
02/2023 - 01/2020
6Therapeutic UsesIBA
12/2022 - 02/2020
6N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2017 - 05/2010
6N-Methylaspartate (NMDA)IBA
10/2016 - 12/2008
5Opioid Receptors (Opioid Receptor)IBA
06/2023 - 01/2018
5Tramadol (K315)FDA LinkGeneric
06/2023 - 01/2019
5BicucullineIBA
05/2023 - 01/2006
5Analgesics (Analgesic Drugs)IBA
01/2023 - 01/2018
5RS 67333IBA
06/2021 - 03/2014
5harman (harmane)IBA
09/2019 - 11/2013
5Messenger RNA (mRNA)IBA
01/2018 - 07/2009
5Glutamic Acid (Glutamate)FDA Link
01/2017 - 06/2006
5LithiumIBA
10/2016 - 11/2006
4AM 251 (AM251)IBA
01/2023 - 03/2013
4Streptozocin (Streptozotocin)FDA Link
12/2022 - 11/2013
4salicylhydroxamic acid (SHAM)IBA
11/2022 - 06/2013
4Arginine (L-Arginine)FDA Link
12/2021 - 06/2006
4NG-Nitroarginine Methyl Ester (L-NAME)IBA
12/2021 - 06/2006
4Scopolamine (Hyoscine)FDA Link
10/2020 - 05/2010
4NeuroaidIBA
06/2020 - 01/2019
4Clonidine (ST 155)FDA LinkGeneric
01/2020 - 07/2003
42,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
09/2019 - 08/2004
4Dopamine Receptors (Dopamine Receptor)IBA
01/2019 - 08/2005
4mu Opioid Receptors (mu Opioid Receptor)IBA
04/2014 - 07/2009
3GABA-A Receptors (GABA(A) Receptor)IBA
04/2024 - 01/2015
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2024 - 01/2019
3Serotonin (5 Hydroxytryptamine)IBA
01/2023 - 11/2013
3QuinpiroleIBA
12/2021 - 08/2004
3Neuroprotective AgentsIBA
01/2021 - 12/2018
3Imipramine (Janimine)FDA LinkGeneric
01/2021 - 07/2003
3Yohimbine (Yocon)IBA
01/2020 - 07/2003
35-HT4 Serotonin ReceptorsIBA
01/2020 - 03/2014
3KetamineFDA LinkGeneric
11/2019 - 06/2016
3Neurotransmitter Agents (Neurotransmitter)IBA
04/2019 - 09/2015
3Dopamine AntagonistsIBA
01/2019 - 08/2013
3azasetronIBA
09/2017 - 03/2014
3Dizocilpine Maleate (Dizocilpine)IBA
04/2016 - 06/2006
3Adrenergic Receptors (Adrenergic Receptor)IBA
01/2016 - 07/2003
3Ethanol (Ethyl Alcohol)IBA
03/2013 - 12/2008
3MecamylamineIBA
07/2008 - 05/2002
2Histamine (Histamine Dihydrochloride)FDA Link
05/2023 - 07/2006
2CitalopramFDA LinkGeneric
12/2022 - 01/2022
2OrexinsIBA
12/2022 - 01/2022
2HarmalineIBA
10/2022 - 10/2014
2EndocannabinoidsIBA
10/2022 - 01/2006
2Thimerosal (Thiomersal)IBA
06/2022 - 05/2018
2Antidepressive Agents (Antidepressants)IBA
01/2022 - 12/2021
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2021 - 06/2006
2Oxidopamine (6 Hydroxydopamine)IBA
12/2021 - 12/2021
2cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
12/2021 - 11/2019
2Cytidine Diphosphate Choline (Citicoline)IBA
01/2021 - 10/2018
2Amyloid (Amyloid Fibrils)IBA
12/2020 - 01/2019
2NeuropeptidesIBA
06/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2018
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2020 - 04/2008

Therapy/Procedure

11Injections
09/2019 - 08/2004
5Analgesia
01/2023 - 09/2017
5Ligation
11/2022 - 06/2013
4Therapeutics
07/2020 - 07/2009
3Transcranial Direct Current Stimulation
01/2019 - 11/2017
2Intraperitoneal Injections
05/2023 - 07/2003
2Cognitive Training
04/2022 - 01/2020